Drugs / BEN2293
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04737304 | Oct 2020 → Jan 2023 | atopic eczema | BenevolentAI Bio | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BEN2293 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04737304 ↗ |
| Route | Topical | “BEN2293 and placebo will be administered as a topical ointment.” NCT04737304 ↗ |